Who makes Up to 900 micrograms Nexvax2?

Up to 900 micrograms Nexvax2 is developed by Nexpep Pty Ltd.

What development phase is Up to 900 micrograms Nexvax2 in?

Up to 900 micrograms Nexvax2 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Up to 900 micrograms Nexvax2

Nexpep Pty Ltd · Phase 1 active Biologic

At a glance

Generic name	Up to 900 micrograms Nexvax2
Sponsor	Nexpep Pty Ltd
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Up to 900 micrograms Nexvax2 CI brief — competitive landscape report
Up to 900 micrograms Nexvax2 updates RSS · CI watch RSS
Nexpep Pty Ltd portfolio CI